A Phase 3, Randomized, Double Blind, Placebo And Active‑Controlled, Multicenter, Parallel‑Group Study Of The Analgesic Efficacy And Safety Of Tanezumab In Adult Subjects With Chronic Low Back Pain
Phase of Trial: Phase III
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Tanezumab (Primary) ; Tramadol
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Acronyms TANGO
- Sponsors Pfizer
- 05 Sep 2017 Planned End Date changed from 16 Jan 2019 to 8 Jan 2019.
- 31 Aug 2017 This trial was discontinued in Denmark, according to European Clinical Trials Database.
- 07 Jul 2017 Planned primary completion date changed from 25 Oct 2017 to 17 Oct 2017.